Add BrightSurf on Google Email

Lab-made virus mimics COVID-19 virus

Researchers created a hybrid virus that targets cells like SARS-CoV-2 but lacks severe disease genes. The hybrid virus can be handled under ordinary laboratory safety conditions, making it ideal for high-throughput analyses.

SourceWashU Medicine·JournalCell Host & Microbe·DateJul 21, 2020

COVID-19 replicating RNA vaccine has robust response in nonhuman primates

A replicating RNA vaccine has shown robust immune response in both young and old animal models, producing antibodies comparable to those in people recovering from COVID-19. The vaccine's design avoids immune responses that could exacerbate the virus, instead inducing protective antiviral measures and T cells.

SourceUniversity of Washington School of Medicine/UW Medicine·JournalScience Translational Medicine·DateJul 20, 2020

The Lancet Global Health: Benefits of routine childhood vaccines far outweigh risks of additional COVID-19 transmission in Africa, modelling study suggests

A modelling study published in The Lancet Global Health found that continuing routine childhood vaccination programmes in Africa during the pandemic could save around 702,000 child lives from vaccine-preventable diseases. This number far exceeds the potential risks of COVID-19 transmission to older family members.

SourceThe Lancet·JournalThe Lancet Global Health·DateJul 17, 2020

COVID-19: Yin and yang and herd immunity

A recent article by the Society for Disaster Medicine and Public Health emphasizes the importance of understanding herd immunity in the context of COVID-19. The authors argue that traditional definitions of a 'case' are inadequate and propose using daily COVID hospital admissions as a more valid measure of the pandemic's medical impact.

SourceSociety for Disaster Medicine and Public Health, Inc.·JournalDisaster Medicine and Public Health Preparedness·DateJul 8, 2020

Norovirus has two alternative capsid structures which change before infection

Scientists from Japan investigate the mouse norovirus structure and find two alternative capsid structures (type A and type B) that switch depending on aqueous conditions. Type B particles show a delay in propagation and reduced adsorption to host cells, suggesting they may evade the immune system before changing to type A for infection.

SourceNational Institutes of Natural Sciences·JournalPLOS Pathogens·DateJul 3, 2020

Tuberculosis vaccine strengthens immune system

A study by universities of Bonn and Nijmegen found that BCG vaccination enhances immune response to multiple infections, including TB and Covid-19. The vaccine's effect is attributed to trained immunity, which allows innate immune cells to become more efficient independently of reinfection.

SourceUniversity of Bonn·JournalCell Host & Microbe·DateJun 15, 2020

Vaccination and moral obligation

Researchers discovered that vaccinated participants were less generous to non-vaccinated individuals than to other vaccinated peers, especially among those who viewed vaccination as a moral duty. This suggests that vaccination is perceived as a societal obligation, transcending social group affiliations.

SourceProceedings of the National Academy of Sciences·JournalProceedings of the National Academy of Sciences·DateJun 15, 2020

New in Ethics and Human Research

Early human challenge trials of SARS-CoV-2 vaccines may be the correct test of ethics, meeting equitable distribution principles. An international governance system is proposed to oversee access to Covid-19 vaccines and treatments.

SourceThe Hastings Center·JournalEthics & Human Research·DateJun 10, 2020

US inroads to better Ebola vaccine

Researchers at Flinders University and US Army Medical Research Institute of Infectious Disease have developed a highly protective Ebola vaccine that appears to be effective against lethal infections in mice. The vaccine, combined with an Advax™ adjuvant, shows promise for preventing future Ebola outbreaks in Africa.

SourceFlinders University·JournalVaccine·DateMay 18, 2020